Full-Time

Business Process Automation Specialist

Posted on 5/18/2025

Agilent Technologies

Agilent Technologies

10,001+ employees

eProcurement services for streamlined purchasing

No salary listed

Mid

Company Does Not Provide H1B Sponsorship

Bawal, India

Category
Business Research
Project Management
Business Development
Business & Strategy
Required Skills
Python
ServiceNow
Java
.NET
Requirements
  • Bachelor’s degree in computer science, Information Technology, or a related field.
  • Relevant Years of experience 3 to 4 Years
  • Proven experience in designing and developing RPA solutions using Blue Prism, Power Automate Desktop, or similar RPA tools.
  • Experience with enterprise systems like Workday, SuccessFactors, Spotfire, Qlik and ServiceNow is advantageous.
  • Strong analytical and problem-solving skills, with the ability to analyze complex processes and develop effective automation solutions.
  • Excellent communication and collaboration abilities, with experience working with cross-functional teams to achieve organizational goals.
  • Ability to work independently and manage multiple projects simultaneously, prioritizing tasks and meeting deadlines.
  • Experience in process mapping, business analysis, and creating detailed documentation.
  • Knowledge of programming languages such as Python, Java, or .NET is a plus, as it can enhance the development and customization of RPA solutions.
Responsibilities
  • Design, develop, and implement RPA solutions to streamline and automate business processes, ensuring they meet business requirements and are scalable.
  • Collaborate with business stakeholders to identify automation opportunities, define requirements, and develop project plans to ensure timely and successful implementation.
  • Analyze and map existing processes to implement efficient automation strategies, focusing on improving process efficiency and reducing operational costs.
  • Develop and maintain comprehensive process documentation, including process maps, technical specifications, and user manuals to support the RPA solutions.
  • Monitor and troubleshoot RPA bots to ensure optimal performance, resolve any issues, and implement improvements to enhance reliability and efficiency.
  • Provide training and support to business users on RPA tools and best practices, ensuring they have the necessary skills to utilize and manage RPA solutions effectively.
  • Stay updated with the latest RPA technologies and industry trends and proactively suggest new tools and methods to improve automation capabilities.
  • Conduct regular reviews and assessments of implemented RPA solutions to identify areas for improvement and optimize performance.
  • Ensure compliance with company policies and industry regulations in the design and implementation of RPA solutions.
  • Lead or participate in workshops and seminars to promote RPA awareness and develop innovative automation strategies.
  • Develop and execute test plans to validate the functionality and performance of RPA solutions before deployment.
  • Coordinate with IT and other departments to integrate RPA solutions with existing systems and workflows.
  • Collaborate with business stakeholders to understand their analytical needs and translate them into technical requirements for RPA or business analytics solutions.
  • Develop and maintain dashboards and reports to track the performance, providing insights and recommendations for further optimization.
  • Utilize data visualization tools and techniques to present complex data in a user-friendly manner, aiding in decision-making and strategic planning.
Desired Qualifications
  • Experience with enterprise systems like Workday, SuccessFactors, Spotfire, Qlik and ServiceNow is advantageous.
  • Knowledge of programming languages such as Python, Java, or .NET is a plus, as it can enhance the development and customization of RPA solutions.

Agilent Technologies provides electronic procurement services that help businesses streamline their purchasing processes. Their suite of eProcurement services allows clients to integrate their pricing into existing platforms, access a hosted catalog, and conduct transactions without paper. This system is designed to help businesses quickly find and purchase the products they need at the right price, enhancing productivity through automation and simplified workflows. Agilent stands out from competitors by focusing on reliability and quality, serving a diverse range of clients who benefit from their expertise. The company's goal is to lower costs and increase profitability for its clients by improving efficiency in procurement.

Company Size

10,001+

Company Stage

IPO

Headquarters

Santa Clara, California

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisitions like Sigsense enhance Agilent's AI capabilities in lab operations.
  • The trend towards paperless transactions boosts Agilent's service efficiency and appeal.
  • Automation in procurement is expected to increase, benefiting Agilent's offerings.

What critics are saying

  • Integration challenges from acquiring BIOVECTRA may disrupt Agilent's operations.
  • Multiple acquisitions could stretch Agilent's resources and management focus.
  • Increased competition from funded companies like RareCyte and Elegen may challenge Agilent.

What makes Agilent Technologies unique

  • Agilent offers a comprehensive suite of eProcurement services for streamlined purchasing.
  • The company focuses on automation and paperless transactions to enhance business productivity.
  • Agilent's hosted catalog and pricing integration simplify procurement processes for clients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Performance Bonus

Stock Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

6%

2 year growth

5%
Business Wire
Jul 30th, 2024
Agilent Acquires Sigsense, Creator of AI-Enabled Lab Operations Technology

Agilent has acquired Sigsense Technologies, a startup that uses artificial intelligence and power monitoring to optimize lab operations.

Biovectra
Jul 22nd, 2024
Agilent Technologies to Acquire BIOVECTRA Inc., Creating New Synergistic Opportunities to Improve Patient Care | BIOVECTRA

CHARLOTTETOWN, Prince Edward Island and SANTA CLARA, California – July 22, 2024 BIOVECTRA Inc. and Agilent Technologies, Inc. (NYSE: A) today announced the signing of an agreement for Agilent to acquire BIOVECTRA, a Canadian-based Contract Development and Manufacturing Organization, from H.I.G. Capital for $925 million. The acquisition provides the ability to expand the range of [...]Read More...

Finsmes
Jun 27th, 2024
RareCyte Secures $20M Financing

RareCyte, a Seattle, WA-based Life Sciences company providing precision biology platforms including instruments, reagents, software, and services, raised $20M in funding

Business Wire
May 14th, 2024
Elegen Raises $35 Million In Series B To Accelerate Expansion Into Clinical Manufacturing

SAN CARLOS, Calif.--(BUSINESS WIRE)--Elegen, the leader in next-generation DNA synthesis and production, today announced a Series B financing of $35 million led by Triatomic Capital. Also joining the round are strategic investors GSK, which recently entered a collaboration and licensing agreement with Elegen to use their proprietary cell-free DNA manufacturing technology in developing GSK’s vaccines and medicines, and John Ballantyne, co-founder of Aldevron. Elegen’s current investors, including Andreessen Horowitz (a16z Bio + Health), KdT Ventures, 8VC, Digitalis Ventures, ACVC Partners, Alix Ventures, AME Cloud Ventures and Agilent Technologies, also participated. The new funds will accelerate the extension of the company’s rapidly growing ENFINIA™ DNA product line across clinical workflows providing turnkey production of GMP-compliant DNA for clinical development of genetic medicines. “The age of genetic medicines is here, but these powerful modalities require innovative new manufacturing approaches to supply the critical input DNA material for rapid discovery, development and then wide-scale production,” said Matthew Hill, Ph.D., Elegen Founder and CEO. “With this investment, we will continue to push the boundaries of DNA synthesis to accelerate upstream discovery and enable rapid and streamlined deployment of new clinical modalities.”

GenomeWeb
Apr 3rd, 2024
Biofidelity Raises $24M to Expand US Commercialization of Lung Cancer Test, Product Pipeline

The firm said it also plans to use the money, which brings its total raised to $60 million, to establish a dedicated manufacturing facility in the UK.